CMT Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CMT Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,134	Closed	-$225K	–	9
2018 Q4	$225K	Buy	+3,134	New	+$253K	1%	10
2018 Q3	–	Sell	-6,282	Closed	-$598K	–	22
2018 Q2	$598K	Buy	+6,282	New	+$577K	3.26%	8
2017 Q3	–	Sell	-6,766	Closed	-$522K	–	33
2017 Q2	$522K	Buy	+6,766	New	+$480K	1.05%	14
2017 Q1	–	Sell	-15,055	Closed	-$891K	–	41
2016 Q4	$891K	Buy	+15,055	New	+$929K	1.07%	13
2015 Q4	–	Sell	-14,105	Closed	-$878K	–	37
2015 Q3	$878K	Buy	+14,105	New	+$1.11M	3.59%	8

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CMT Trading's XBI Position: Q1 2019 in Review

CMT Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2019, closing a stake of 3,134 shares — an estimated $225K sold.

CMT Trading first reported a position in XBI in Q3 2015 and held it in 5 quarters. The position peaked at $891K in Q4 2016. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

CMT Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2019 after selling out during the quarter.
CMT Trading sold 3,134 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $225K.
CMT Trading first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 5 quarters.
CMT Trading's State Street SPDR S&P Biotech ETF position peaked at $891K in Q4 2016.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on CMT Trading's 13F filing for Q1 2019.